Navigation Links
Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Date:8/2/2012

r respiratory tract infection.  ETI-204 is formulated as a solution suitable for either IV or intramuscular (IM) administration.  This project is supported with federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), the Department of Health and Human Services (HHS) under Contract Nos. HHSO100201000026C and HHS0100201100034C.

About Elusys Therapeutics, Inc.

Elusys Therapeutics, a private company based in Pine Brook, NJ, is focused on the development of antibody therapeutics for the treatment of life-threatening disease. Elusys has been engaged in development of biodefense countermeasures since 2000. The company has established experience in government contract management and to date has received multiple grants and has the potential to receive, in total, up to $246 million in government funding. ETI-204, a highly effective, anthrax anti-toxin, is in late-stage development and is a strong candidate for future procurement into the Strategic National Stockpile. For more information, please visit www.elusys.com.

SAFE HARBOR STATEMENT                                                                                                     This announcement includes statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  This release includes forward looking
'/>"/>

SOURCE Elusys Therapeutic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)
2. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
3. Engineer-turned-librarian awarded travel stipend by SPIE Digital Library
4. Delpor Awarded $340K NIH Grant for 3-month Long Acting Risperidone Product in order to Improve Medication Adherence in Schizophrenia and Bipolar Disorder
5. Produce Safety Researchers Awarded by ABC Research Laboratories
6. Cohera Medical Awarded Platform Patent on its Biodegradable Adhesive Technology
7. CELEXION Awarded Patent on Biosynthesis of Renewable Chemicals
8. Chemring Detection Systems Awarded $9M for Biological Detection Systems
9. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
10. Chemring Detection Systems Awarded $500k for Strategic Research and Development
11. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 During the conduct of ... adhere to principles of good clinical practice (GCP) ... Dr. Jeremy Lim, Fellow, Clinical Development at Novartis ... ,     Understand the International Conference on Harmonization (ICH) ... regulations for the conduction of clinical trials , ...
(Date:5/23/2013)... Bed bugs compromised Penn State. A report ... Meanwhile, My Cleaning Products offered complimentary samples of its bed ... without using harmful chemical elements. , Based on the ... building was actually a dormitory , My Cleaning Products ... May 13 and bed bug presence was confirmed on May ...
(Date:5/22/2013)... Industry leaders from around the ... Oak Ridge National Laboratory’s Biosurveillance Symposium ... the Hilton Alexandria Mark Center. Held in conjunction ... conference on June 18 - 19. , Join ... Elements, Applied Research Associates, ARA, AttaGene, Battelle, Benedictine ...
(Date:5/22/2013)... 22, 2013  Empire Genomics announced today it ... pending novel genomic biomarker from Cornell University for ... could help in diagnosing and determining treatment for ... Neuroendocrine prostate cancer (NEPC) is a lethal ... de novo, but more commonly arises after hormonal ...
Breaking Biology Technology:Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Novagali Pharma, a French,pharmaceutical ophthalmic company, announces ... (IND) to conduct a Phase III clinical,trial ... glaucoma has been,granted by the U.S. Food ... ocular proprietary BAK-free formulation of latanoprost which,furthermore ...
... Milestone Payment from GlaxoSmithKlineMOUNTAIN VIEW, Calif., May 5 ... identified an orally bioavailable small molecule antagonist of ... clinical development. The acceptance of the molecule ... milestone payment from the alliance with GlaxoSmithKline (NYSE: ...
... May 5 Amylin Pharmaceuticals, Inc., (Nasdaq: ... LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) ... once weekly has been submitted to the U.S. Food and ... release medication for type 2 diabetes that is injected subcutaneously ...
Cached Biology Technology:Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 3ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
(Date:5/22/2013)... human health effects from disposal of millions of ... to recommend stronger government policies to encourage recovery, ... That,s the conclusion of a new paper in ... . , Oladele A. Ogunseitan and colleagues point ... powering everything from smart phones to components in ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... into an aggressive sexual frenzy. Researchers writing in the ... a urine-mediated combination of aggressive and reproductive behaviour ensures ... Fiona Berry and Thomas Breithaupt from the University of ... on sexually active crayfish. Breithaupt said, "Our results confirm ...
... SEATTLE University of Washington (UW) researchers have gathered ... by overproducing protein-digesting enzymes. Plaques are fat-laden rough spots ... plaque ruptures, blood accumulates inside of it, a process ... clots can form. If the flow of oxygen-rich blood ...
... Five prominent physicists from leading U.S. and European universities will ... a daylong symposium presented by the Physics Department at The ... April 23, at The Harmonie Club in New York, will ... doctorate on Sy Sternberg, ,65 EE, former chairman and chief ...
Cached Biology News:Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 2Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 3Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 4CCNY symposium April 23 to explore future of physics 2CCNY symposium April 23 to explore future of physics 3
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
... DNA Ligase catalyzes the joining of two ... the 3´-hydroxyl groups of adjacent nucleotides in ... The enzyme has also been shown to ... a DNA or RNA strand in a ...
... to MAP1 Light Chain MAP1A and MAP1B ... between microtubules and components of the cytoskeleton. MAP1A ... subunit and multiple light chain subunits. The protein ... light chain subunits and can associate with either ...
PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Biology Products: